EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis.
Date
2017-01-10
Journal Title
Journal ISSN
Volume Title
Publisher
Citation
Ihira, K, Dong, P, Xiong, Y, Watari, H, Konno, Y, Hanley, S J B, Noguchi, M, Hirata, N, Suizu, F, Yamada, T, Kudo, M & Sakuragi, N 2017, 'EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis.', Oncotarget, vol. 8, no. 8, pp. 13509-13520. https://doi.org/10.18632/oncotarget.14586